@article {Comin, author = {J. Comin and D. Kallmes}, title = {Clopidogrel (Plavix)}, year = {2011}, doi = {10.3174/ajnr.A2913}, publisher = {American Journal of Neuroradiology}, abstract = {SUMMARY: Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic stroke and in-stent thrombosis. However, it has a number of drawbacks, including an increased risk of hemorrhage; a clinical effect that is slow in onset and irreversible; a genetically determined variability in its clinical potency; and interactions with other commonly administered drugs. Abbreviations Act-Metactive metabolite of clopidogrelADPadenosine diphosphateAHAAmerican Hospital AssociationGIgastrointestinalGPIIb/IIIaglycoprotein IIb/IIIaPPIproton pump inhibitorVWFvon Willebrand factor}, issn = {0195-6108}, URL = {https://www.ajnr.org/content/early/2011/12/01/ajnr.A2913}, eprint = {https://www.ajnr.org/content/early/2011/12/01/ajnr.A2913.full.pdf}, journal = {American Journal of Neuroradiology} }